Bharti Airtel: Quotes, News

BSE 1835.4031.8 (-1.73%)

NSE 1834.9032.8 (-1.79%)

Ranbaxy Labs:

Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.

Kumar told CNBC-TV18, "Most of the worst is behind for the Ranbaxy at this point in time and given the near-term triggers in the form of techno launches which is scheduled for December end, some of the positive commentary coming on."

He further added, "This stock is not being purely valued at this point in time. So I think you can still look at stocks running upto Rs 620-630 and that is where I think we are looking at in terms of the target price and we still have a buy rating on this stock."

Jubilant Foodworks:

Aditya Birla Money is bearish on Jubilant Foodworks (JFW) and has recommended reduce rating on the stock with a target of Rs 1124 in its November 8, 2012 research report.

"JFW net sales increased by 42.3% YoY to Rs3420.4 mn mainly led by 19.8% SSS growth and opening of 26 new Domino's stores in 2QFY13 (thereby reaching total store count to 515) . The company has opened 1 additional store in Sri Lanka taking total store count to 3. For FY13, the company has once again revised its store opening target from earlier 100 to 110 (at the start of FY13, target was 90). Based on the guidance of store opening target and proven ability of the company to deliver on the same, in our assumption, we have revised the number of new stores to be opened in FY13E and FY14E to 110 and 100 respectively."

Bharti Airtel:

KRChoksey is bullish on Bharti Airtel and has recommended buy rating on the stock with a target of Rs 322 in its November 8, 2012 research report.

"Bharti Airtel's, net revenues increased by 4.8% over Q1FY13 to Rs 20283crs mainly driven by revenue growth in other business verticals of India business and revenue growth in Africa market. India voice segment disappointed on net subscriber base which declined by 1% QoQ to 185.9mn and ARPU was lower by 4% to Rs 177 led by seasonally weak quarter. Voice ARPU declined by 4% QoQ to Rs 148. Data segment reported growth in both subscriber base and ARPU by ~8% QoQ. MoUs declined by 4% over Q1FY13 to 417mins. On Africa front, net subscriber base increased by 6% QoQ to 58.6mn. In spite of 14% increase in MoUs, ARPU declined by 2% to USD 6.4. Stiff competitive environment and regulatory overhang will put pressure on revenue growth."

Motherson Sumi:

SPA Research is bullish on Motherson Sumi Systems (MSSL) and has recommended buy rating on the stock with a target of Rs 197 in its November 7, 2012 research report.

"MSSL reported net sales of INR 59 bn, up by 151.8% YoY & down by 7.8% QoQ. Net sales excluding SMP stood at INR 29.3 bn, up by 25.6% YoY & down by 5.3% QoQ. It derived ~82% of its revenues from overseas market and ~18% from India. Domestic sales and Export sales grew by 18% and 235% (28% excluding SMP) respectively. EBITDA margin stood at 7%, down by 17 bps QoQ due to higher employee cost partly offset by lower COGS.

GoodReturns.in

DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.